Liposaccharide natural compounds consisting of a trisaccharide repeating unit (two heptose units and octulosonic acid) with oligosaccharide side chains and 3-hydroxytetradecanoic acid units (they are a major constituent of the cell walls of Gram-negative bacteria).
Chemical ID:
MESH:D008070
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; 3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL3 mRNA]; [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CCL3 mRNA; [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CCL3 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of CCL3 mRNA; Albuterol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]]]; Dinoprostone promotes the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]]; Dinoprostone promotes the reaction [roflumilast N-oxide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]]; Dobutamine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; honokiol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; Ibuprofen inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]]; Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; roflumilast N-oxide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]
Lipopolysaccharides results in increased expression of CCL3; Lipopolysaccharides results in increased expression of CCL3 mRNA; Lipopolysaccharides results in increased expression of CCL3 protein
3,4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; 5-aminoisoquinolinone inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; [3-methylquercetin co-treated with Lipopolysaccharides] affects the expression of CCL3 mRNA; [Quercetin co-treated with Lipopolysaccharides] affects the expression of CCL3 mRNA; [Shiga Toxin 2 co-treated with Lipopolysaccharides] results in increased expression of CCL3 mRNA; astragalin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; bardoxolone methyl inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased secretion of CCL3 protein]; Cathelicidins inhibits the reaction [[Shiga Toxin 2 co-treated with Lipopolysaccharides] results in increased expression of CCL3 mRNA]; coagulin-L inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; Cyclic AMP inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; Dinoprostone inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; DUSP1 gene mutant form inhibits the reaction [Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]]; Epinephrine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; Epinephrine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; IL6 protein affects the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; Isoproterenol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; Lipopolysaccharides results in increased expression of and results in increased secretion of CCL3 protein; luteolin 3'-glucuronide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; luteolin-7-O-glucuronide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; methyldithiocarbamate inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; Niclosamide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; Norepinephrine inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; Norepinephrine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; PARP1 protein affects the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; PARP1 protein affects the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; Propranolol inhibits the reaction [Norepinephrine inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]]; Propranolol promotes the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; Quercetin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; Resveratrol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]; Rolipram inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; Rolipram inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; terameprocol affects the reaction [Lipopolysaccharides results in increased expression of CCL3 protein]
ADM protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; CALCA protein inhibits the reaction [Lipopolysaccharides results in increased expression of CCL3 mRNA]; cannabigerol inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]; VCE-003 inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]